Shawn P Griffin

16PUBLICATIONS
28CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursClinical pharmacy and pharmacy practiceClinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 13, 2026
Oncology pharmacist survey: Understanding task value and professional satisfaction.

Lydia L Benitez, Jessie Signorelli, Kristin Adler

|Nov 12, 2025
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|May 21, 2025
Comparison of standard versus adjusted dose of enoxaparin for venous thromboembolism prophylaxis in patients with obesity and cancer.

Cody Angerman, Jiyong Ahn, Kendra Gee-Rodriguez

|Apr 02, 2025
Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network.

Shawn P Griffin, Jessie Signorelli, Farah Raheem

|Oct 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Oct 12, 2024
Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.

Benjamin J Lee, Jenny Liu, Shawn P Griffin

Pageof 3

Frequent Collaborators

12 joint publications

Benjamin J Lee

8 joint publications

Stefan O Ciurea

7 joint publications

Jean Doh

7 joint publications

Piyanuch Kongtim